Assignee
DILAFOR AB
SE·5 granted patents·5 pending applications·2 citations·filing 2003–2025
Top patents by PatentIndex Score
10 records- 0165US2023355658A1Medical use of tafoxiparinDILAFOR AB·Filed 2023·Application pending·0 cites
- 0265US2025360160A1New medical use of tafoxiparinDILAFOR AB·Filed 2023·Application pending·0 cites
- 0363US12419904B2Medical use of tafoxiparinDILAFOR AB·Filed 2025·Granted Sep 23, 2025·0 cites·30 claims
- 0460US7407945B2Use of sulfated glycosaminoglycans for establishing effective labor in womenDILAFOR AB·Filed 2003·Granted Aug 5, 2008·2 cites·11 claims
- 0555US12502403B2Tafoxiparin for the treatment of preeclampsiaDILAFOR AB·Filed 2021·Granted Dec 23, 2025·0 cites·20 claims
- 0643US2015057226A1Method for treatment of labor arrestDILAFOR AB·Filed 2013·Application pending·0 cites
- 0737US10023659B2Processes for the production of chemically-modified heparinsDILAFOR AB·Filed 2014·Granted Jul 17, 2018·0 cites·17 claims
- 0836US2015045322A1Combination treatment comprising sulphated glycosaminoglycans for inducing laborDILAFOR AB·Filed 2013·Application pending·0 cites
- 0936US2015099703A1Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agentDILAFOR AB·Filed 2013·Application pending·0 cites
- 1035US9475888B2Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical useDILAFOR AB·Filed 2012·Granted Oct 25, 2016·0 cites·24 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →